Protein and vitamin B6 intake are associated with liver steatosis assessed by transient elastography, especially in obese individuals
- PMID: 28750503
- PMCID: PMC5628006
- DOI: 10.3350/cmh.2017.0019
Protein and vitamin B6 intake are associated with liver steatosis assessed by transient elastography, especially in obese individuals
Abstract
Background/aims: Although the detrimental effects of several dietary components on the promotion of nonalcoholic fatty liver disease are well known, no studies have assessed the role of dietary vitamin B6. Moreover, studies on the associations between dietary components or body composition indices and liver steatosis assessed by transient elastography are rare. Our aim was to identify the nutritional factors and anthropometric parameters associated with liver steatosis.
Methods: In this cross-sectional study, we enrolled 168 individuals (35% obese) who underwent a liver steatosis assessment by Controlled Attenuation Parameter measurement and nutritional assessment.
Results: Tertiles of vitamin B6 intake were positively associated with hepatic steatosis (B=1.89, P=0.026, confidence interval [CI] 0.03-0.80) as well as with triglycerides, glucose, alanine aminotransferase (ALT), and body mass index . In obese individuals, after multivariable analysis, the Controlled Attenuation Parameter score was still associated with triglycerides, ALT, and total protein intake (B=0.56, P=0.01, CI 0.10-1.02). Participants in tertile I (low intake) had a lower Controlled Attenuation Parameter than those in tertile III (P=0.01).
Conclusions: We found a positive association between hepatic steatosis or Controlled Attenuation Parameter score and vitamin B6/total protein intake, probably related to the high intake of meat. Vitamin B6 might have a pathogenic role related to the increase of hepatic steatosis.
Keywords: Elastography; Fatty liver; Obesity; Proteins; Vitamin B6.
Conflict of interest statement
Similar articles
-
MEASUREMENT OF CONTROLLED ATTENUATION PARAMETER: A SURROGATE MARKER OF HEPATIC STEATOSIS IN PATIENTS OF NONALCOHOLIC FATTY LIVER DISEASE ON LIFESTYLE MODIFICATION - A PROSPECTIVE FOLLOW-UP STUDY.Arq Gastroenterol. 2018 Jan-Mar;55(1):7-13. doi: 10.1590/S0004-2803.201800000-07. Arq Gastroenterol. 2018. PMID: 29561981
-
Usefulness of Transient Elastography for Non-Invasive Diagnosis of Liver Fibrosis in Pediatric Non-Alcoholic Steatohepatitis.J Korean Med Sci. 2019 Jun 17;34(23):e165. doi: 10.3346/jkms.2019.34.e165. J Korean Med Sci. 2019. PMID: 31197983 Free PMC article.
-
Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening.Arch Iran Med. 2021 Mar 1;24(3):177-186. doi: 10.34172/aim.2021.28. Arch Iran Med. 2021. PMID: 33878875
-
Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.Dig Dis Sci. 2017 Aug;62(8):2150-2158. doi: 10.1007/s10620-017-4592-0. Epub 2017 May 18. Dig Dis Sci. 2017. PMID: 28523578
-
Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?World J Gastroenterol. 2016 Aug 28;22(32):7236-51. doi: 10.3748/wjg.v22.i32.7236. World J Gastroenterol. 2016. PMID: 27621571 Free PMC article. Review.
Cited by
-
Supplementation of Micro- and Macronutrients-A Role of Nutritional Status in Non-Alcoholic Fatty Liver Disease.Int J Mol Sci. 2024 Apr 30;25(9):4916. doi: 10.3390/ijms25094916. Int J Mol Sci. 2024. PMID: 38732128 Free PMC article. Review.
-
Citrus Bergamia and Cynara Cardunculus Reduce Serum Uric Acid in Individuals with Non-Alcoholic Fatty Liver Disease.Medicina (Kaunas). 2022 Nov 26;58(12):1728. doi: 10.3390/medicina58121728. Medicina (Kaunas). 2022. PMID: 36556930 Free PMC article. Clinical Trial.
-
Hepatoprotective Effects of Ixeris chinensis on Nonalcoholic Fatty Liver Disease Induced by High-Fat Diet in Mice: An Integrated Gut Microbiota and Metabolomic Analysis.Molecules. 2022 May 14;27(10):3148. doi: 10.3390/molecules27103148. Molecules. 2022. PMID: 35630624 Free PMC article.
-
Associations between one-carbon metabolism and valproic acid-induced liver dysfunction in epileptic patients.Front Pharmacol. 2024 Feb 23;15:1358262. doi: 10.3389/fphar.2024.1358262. eCollection 2024. Front Pharmacol. 2024. PMID: 38464726 Free PMC article.
-
Association between the index of nutritional quality and lipid profile in adult women.Endocrinol Diabetes Metab. 2022 Sep;5(5):e358. doi: 10.1002/edm2.358. Epub 2022 Jul 20. Endocrinol Diabetes Metab. 2022. PMID: 35856460 Free PMC article.
References
-
- Ekstedt M, Franzén LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44:865–873. - PubMed
-
- Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence and outcomes. Hepatology. 2016;64:73–84. - PubMed
-
- Maciejewska D, Ossowski P, Drozd A, Ryterska K, Jamioł-Milc D, Banaszczak M, et al. Metabolites of arachidonic acid and linoleic acid in early stages of non-alcoholic fatty liver disease--A pilot study. Prostaglandins Other Lipid Mediat. 2015;121(Pt B):184–189. - PubMed
-
- Vonakis BM, Vanderhoek JY. 15-Hydroxyeicosatetraenoic acid (15-HETE) receptors. Involvement in the 15-HETE-induced stimulation of the cryptic 5-lipoxygenase in PT-18 mast/basophil cells. J Biol Chem. 1992;267:23625–23631. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical